The benefits of a four-day workweek according to a champion of the trend
Tempur Sealy to divest more than 100 stores in bid to close $4 billion Mattress Firm deal
Biohaven's genetic disease drug meets main trial goal
Argentina dollar deposits spike by $8 billion under Milei
UAE seeks closer AI, tech ties in Biden talks as China interest stirs US concern
India reports first case of mpox from new, fast-spreading clade 1b variety
ABBA’s Björn Ulvaeus marries for third time, with ‘Bake Off’ star Sandi Toksvig officiating
Carlos Alcaraz leads Team Europe to comeback victory over Team World in the Laver Cup
Cathay Pacific bans couple after seat-reclining spat
LONDON (Reuters) - Nearly 30,000 suspected mpox cases have been reported in Africa so far this year, most of them in Democratic Republic of Congo where tests have run out, the World Health Organization said on Monday.
More than 800 people died of suspected mpox across the continent in that time, the U.N. health body said in its report. Congo's central African neighbour Burundi has also been hit by a growing outbreak, it added.
Mpox can spread through close contact. Usually mild, it is fatal in rare cases. It typically causes flu-like symptoms and pus-filled lesions on the body.
The WHO statement did not give comparative figures from previous years. The African Union's public health agency has said 14,957 cases and 739 deaths were reported from seven affected states in 2023 - a 78.5% increase in new cases from 2022.
There were 29,342 suspected cases and 812 deaths across Africa from January to Sept. 15 this year, according to the WHO report.
A total of 2,082 confirmed cases were reported across the world in August alone, the highest since November 2022, the WHO said.
On Saturday, the World Bank's pandemic fund said it would give $128.89 million to ten African countries to help fight the outbreak.
(Reporting by Jennifer Rigby; Editing by Andrew Heavens)
